Honoring our roots, caring for our community.

Investigational · not FDA-approved

BPC-157: what research does and does not show

Educational information about an investigational peptide that is not FDA-approved: research, limits, risks and regulatory status.

Evidence-based care Individualized plan
BPC-157

Introduction

BPC-157: separating research from proven care

BPC-157 is widely discussed for injury recovery and gut health. This page explains what research has looked at, what has and has not been shown in people, and its regulatory status.

BPC-157 is not an FDA-approved medicine. If you have an injury or digestive symptoms, a medical evaluation helps identify proven treatment options.

Overview

What is BPC-157?

BPC-157 ("body protection compound") is a synthetic peptide of 15 amino acids, based on part of a protein found in human gastric juice. It is not a natural hormone and is not the same as any approved medicine.

Research

Areas of research

These are research topics, mostly in animals, not proven treatments.

Tendon, ligament and muscle healing

Studied mainly in rodents.

Stomach and intestinal lining

Studied in animal models of injury.

Blood vessel growth

Observed in laboratory studies.

Inflammation

Explored in cell and animal studies.

Evidence

Preclinical studies versus human evidence

Most BPC-157 research comes from animal and laboratory studies. Results in animals often do not translate to people.

Human data are limited to a few very small studies without the control groups needed to show benefit. There are no well-designed clinical trials showing that BPC-157 heals injuries or treats digestive disease in people.

Next step

Talk with a provider first

If you have an injury or digestive symptoms, a medical evaluation helps identify proven options.

Request a medical consultation

Regulatory status

Current regulatory status

BPC-157 is not FDA-approved for any use. The FDA has evaluated whether it may be used in compounded drugs and has raised safety concerns, including possible immune reactions and impurities; that review was ongoing in 2026. An advisory committee recommendation is not an FDA approval.

BPC-157 is prohibited in sport by the World Anti-Doping Agency. Products sold online "for research" are not made for human use, and their quality is unknown.

Limitations

Limitations of efficacy and safety

No proven benefit in people

Animal results are not evidence of human benefit.

Unknown long-term safety

No long-term human studies exist.

Variable product quality

Purity and content can differ between sources.

Unknown interactions

Interactions with medicines have not been studied.

Risks

Known and unknown risks

Injection-site reactions

Redness, pain or swelling.

Reported symptoms

Nausea, dizziness, headache or flushing.

Immune reactions

A concern raised by the FDA.

Effects on tumor growth

Unknown; it promotes blood vessel growth in the lab.

Impurities

Especially in unregulated products.

Long-term effects

Not known.

Safety

Who should not use it

BPC-157 may not be appropriate, and should be discussed with a provider, if any of the following apply to you:

  • Pregnancy or breastfeeding (consult your provider)
  • Active cancer or a history of cancer
  • Competitive athletes subject to anti-doping testing
  • Allergy to any ingredient
  • Children and adolescents under 18

FAQ

BPC-157 FAQs

Clear answers to help you prepare.

No. BPC-157 is not FDA-approved for any use, and the FDA has raised safety concerns about its use in compounded drugs.

No. These effects have been studied mainly in animals. There are no well-designed human trials showing these benefits.

Its safety in people is not established, especially over the long term, and product quality varies.

No. It is prohibited by the World Anti-Doping Agency.

Any medicine, dose, route and schedule are decided only by a licensed provider after an individual evaluation. This page is educational and does not give treatment instructions.

Information on this page is educational and does not replace medical evaluation. Treatment options are determined individually.